The clinical management of ductal carcinoma in situ, lobular carcinoma in situ and atypical hyperplasia of the breast

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

Medicine, Oncology, Preventive Medicine +15

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

The Lancet · 1997 · 2.5K citations · Full text

Medicine, Endocrinology, Oncology +15

Risk Factors for Breast Cancer in Women with Proliferative Breast Disease

William D. Dupont, David L. Page · New England Journal of Medicine · 1985 · 1.9K citations

Medicine, Oncology, Pathology +17

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Bernard Fisher, James J. Dignam, Norman Wolmark et al. · The Lancet · 1999 · 1K citations

Medicine, Gynecology, Oncology +12